Search

everythinglearnresearchcommunity

for

Search:↓

The treatment successfully lowered testosterone levels and reduced symptoms.

ZSYY001 is safe, well-tolerated, and shows promise for treating advanced solid tumors.

High-dose methotrexate can cause severe skin and nail issues.

Second-generation antipsychotics offer no significant benefit over first-generation ones for schizophrenia.

Tofacitinib may effectively treat skin symptoms in difficult cases of dermatomyositis.

The treatment was not recommended due to limited effectiveness and significant side effects.

Tofacitinib effectively reduces hair loss in children with alopecia areata but may cause mild side effects and relapses.

Agomelatine might help reduce hair loss caused by valproate.

People from iodine-deficient areas are more likely to develop hypothyroidism when treated for multi-drug resistant tuberculosis.

Bevacizumab may worsen hypothyroidism, so thyroid function should be monitored during treatment.

A woman got male pattern baldness from touching her husband's testosterone gel.

Finasteride blocks deoxycorticosterone's anticonvulsant effects in infant rats, but indomethacin doesn't.

Microinfusion of methotrexate can help treat frontal fibrosing alopecia.

Long-term treatment with palbociclib plus letrozole maintains quality of life in certain breast cancer patients.

A boy with chromosome 13q deletion syndrome developed eye cancer, a woman with breast cancer lost vision due to a rare side-effect of her treatment, a man's vision worsened after using a hair loss drug, and two rare disorders were discussed. Optical Coherence Tomography is useful for diagnosing and monitoring these conditions.

Combining low-dose oral minoxidil with immunomodulators shows promise for treating alopecia areata but needs more research.

Methotrexate effectively managed SAPHO syndrome symptoms when other treatments failed.

Exemestane is effective and safe for treating certain breast cancers, with mild side effects, but needs more research on long-term effects.

Pazopanib treatment caused rapid hair color loss, possibly indicating its effectiveness.

Calcipotriol is the safest and most effective for hair regrowth in localized alopecia areata.

Sodium valproate can cause severe liver disease and side effects, sometimes leading to death.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Terbinafine can cause skin reactions when exposed to sunlight, so sun exposure should be avoided during treatment.

Some breast cancer patients treated with high-dose docetaxel may experience permanent hair loss.

Suppressing ODC activity reduces tumor growth in hair follicles.

The drug TGU was ineffective against small cell lung cancer and caused significant bone marrow suppression.

Mefloquine was generally safe at 500 mg weekly, but higher doses caused nausea and diarrhea.

Topical minoxidil successfully treated temporal triangular alopecia.

Agomelatine might help stop hair loss caused by valproate.

Most children with skin inflammation taking methotrexate had lab abnormalities, but liver issues often improved without changing the medication dose.